Sarah leads IFPMA’s regulatory workstream on Biotherapeutic and Advanced Therapies at the international level. She is also responsible for overseeing regulatory policy and advocacy activities in Africa and beyond.

This includes engagement with various key global stakeholders and regional organizations involved in regulatory harmonization and system strengthening to improve access to medicinal products to benefit patients.

Previously, Sarah worked in regulatory and scientific affairs at the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Working in academia, Sarah spent more than 10 years researching into pulmonary and pancreatic disease preclinical drug testing and vaccine development. Sarah was an appointed lecturer at the School of Pharmacy at the University of Geneva. She holds a PhD degree in Molecular Biology and an Engineering degree in Biotechnology.

Collaborations and partnerships like those supported by IFPMA are crucial. Whatever link you have in the chain enables the changes and advancements needed to accelerate access to medicinal products for patients worldwide.